---
author: Harvey Guo
created: 2024-03-17 22:00
modified: 2024-03-17 22:00
aliases:
  - Celecoxib
  - Acetaminophen
  - NSAIDs
share: true
---
![[../../assets/img/Pasted image 20240317220254.png|Pasted image 20240317220254.png]]
# Nonsteroidal anti-inflammatory drugs (NSAIDs)
## Agents
- <span style="background:rgba(240, 200, 0, 0.2)">Ibuprofen</span>
- Diclofenac
- Indomethacin
- <span style="background:rgba(240, 200, 0, 0.2)">Naproxen</span>
- Piroxicam
- Meloxicam
- Ketorolac
- Sulindac
- Aspirin
## Mechanism of action
- Reversible inhibition of the enzymes COX-1 and COX-2 → decreased prostaglandin synthesis 
- Aspirin is the exception, because it leads to irreversible COX-1 and COX-2 inhibition.
## Choice
- <span style="background:rgba(240, 200, 0, 0.2)">Acetaminophen</span>
	- For mild to moderate pain
	- <span style="background:rgba(240, 200, 0, 0.2)">Safe</span>
	- Can be used by children and pregnant women
- <span style="background:rgba(240, 200, 0, 0.2)">Ibuprofen</span>
	- For <span style="background:rgba(240, 200, 0, 0.2)">acute</span>, mild to moderate pain
	- <span style="background:rgba(240, 200, 0, 0.2)">Works fast</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Naproxen</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Strong and long-lasting</span>
	- May affect [[../Pathology/Wound healing|wound healing]]
- <span style="background:rgba(240, 200, 0, 0.2)">Aspirin</span>
	- Only salicylate among NSAIDs
	- <span style="background:rgba(240, 200, 0, 0.2)">Commonly used as antiplatelet agents, instead of analgesics or anti-inflammatory agents</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">See [[./Salicylate poisoning|Salicylate poisoning]] for overdose effects</span>
- For mild to moderate pain accompanied by swelling and inflammation, non-steroidal anti-inflammatory drugs (such as ibuprofen, aspirin, and naproxen) are more effective.
# Selective COX-2 inhibitors
## Agent
Celecoxib
## Mechanism of action
<span style="background:rgba(240, 200, 0, 0.2)">Reversible selective inhibition of COX-2 with almost no inhibition of COX-1</span>
>[!Mnemonic] 
>Selecoxib
## Effects
- Analgesic and anti-inflammatory
- Advantages in comparison to nonselective NSAIDs
	- <span style="background:rgba(240, 200, 0, 0.2)">No antiplatelet effect</span>: platelets only possess COX-1 and are therefore not targeted by selective COX-2 inhibitors. This means that the activity of thromboxane A2 (TXA2) is not interrupted (TXA2 normally promotes platelet aggregation).
	- Gastric mucosal cells express mostly COX-1, which is involved in maintaining a healthy gastric mucosa, so there are <span style="background:rgba(240, 200, 0, 0.2)">minimal gastrointestinal side effects and a lower risk of gastric ulcers</span>.
## Indications
- [[../MSK/Rheumatoid arthritis|Rheumatoid arthritis]], [[../MSK/Osteoarthritis|osteoarthritis]]
# Other non-opioid analgesics
## Agent
<span style="background:rgba(240, 200, 0, 0.2)">Acetaminophen</span>
## Mechanism of action
- <span style="background:rgba(240, 200, 0, 0.2)">Reversibly inhibits cyclooxygenase, mainly in the CNS</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Inactivated peripherally</span>
## Effects
- Antipyretic
- Analgesic
- <span style="background:rgba(240, 200, 0, 0.2)">No anti-inflammatory effect</span>
## Side effects
- Hepatotoxicity due to acetaminophen overdose (drug-induced hepatitis)
	- <span style="background:rgba(240, 200, 0, 0.2)">Leading cause of acute hepatic failure in the US</span>
- Pathophysiology
	- Exhaustion of hepatic metabolic pathways causes <span style="background:rgba(240, 200, 0, 0.2)">increased formation of a toxic metabolite of acetaminophen</span>, N-acetyl-p-benzoquinoneimine (<span style="background:rgba(240, 200, 0, 0.2)">NAPQI</span>).
		- Glutathione initially inactivates NAPQI, but its reserves are eventually depleted, leading to <span style="background:rgba(240, 200, 0, 0.2)">NAPQI build-up</span>.
		- NAPQI → irreversible oxidative hepatocyte injury → <span style="background:rgba(240, 200, 0, 0.2)">liver cell necrosis</span>
- Clinical features
	- Nonspecific symptoms (nausea, vomiting, pallor lethargy) or asymptomatic in the first 24 hours after ingestion
	- Progressive liver impairment (RUQ pain, liver enlargement and tenderness, abnormal liver function tests)
	- If acute liver failure does not develop, patients typically begin to recover within 2 weeks after ingestion.
	- Acute kidney failure occurs in approx. 50% of patients with acute hepatic failure. 
- Antidote: PO or IV <span style="background:rgba(240, 200, 0, 0.2)">N-acetylcysteine (NAC)</span>
	- NAC replenishes glutathione stores in the liver

